BioAge Labs (BIOA) Equity Ratio (2023 - 2026)

BioAge Labs has disclosed Equity Ratio across 4 years of filings, most recently posting 0.95 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.95, up 4.68% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.95 (up 4.68% YoY), and the FY2025 annual result was 0.92, up 2.28% from the prior year.
• Equity Ratio came in at 0.95 for Q1 2026 at BioAge Labs, up from 0.92 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.95 in Q1 2026 to a low of 6.69 in Q4 2023.
• The 4-year median for Equity Ratio is 0.91 (2025), against an average of 0.03.
• Across the five-year window, Equity Ratio jumped 113.49% in 2024 and dropped 2.2% in 2025, its largest moves.
• BioAge Labs' Equity Ratio stood at 6.69 in 2023, then surged by 113.49% to 0.9 in 2024, then gained by 2.28% to 0.92 in 2025, then climbed by 3.34% to 0.95 in 2026.
• The last three Equity Ratio figures came in at 0.95 (Q1 2026), 0.92 (Q4 2025), and 0.91 (Q3 2025), per Business Quant data.